New Age Alpha Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216K Sell
3,681
-145
-4% -$6.08K 0.01% 750
2026
Q1
$123K Sell
3,826
-93
-2% -$3.44K 0.01% 670
2025
Q4
$165K Buy
+3,919
New +$158K 0.01% 634

Other funds holding VCYT

New Age Alpha Advisors's VCYT Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Veracyte (VCYT) stake by 3.8% in Q2 2026, selling an estimated $6.08K and leaving 3,681 shares worth $216K. The position accounts for 0.01% of the portfolio, ranked #750.

New Age Alpha Advisors first reported a position in VCYT in Q4 2025 and has held it in 3 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • New Age Alpha Advisors held 3,681 shares of Veracyte worth $216K as of Q2 2026.
  • New Age Alpha Advisors sold 145 Veracyte shares in Q2 2026, an estimated $6.08K.
  • Veracyte made up 0.01% of New Age Alpha Advisors's portfolio in Q2 2026, its #750 holding.
  • New Age Alpha Advisors first reported a position in Veracyte in Q4 2025 and has held it in 3 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.